Authors:
Davis, SJ
Ikemizu, S
Collins, AV
Fennelly, JA
Harlos, K
Jones, EY
Stuart, DI
Citation: Sj. Davis et al., Crystallization and functional analysis of a soluble deglycosylated form of the human costimulatory molecule B7-1, ACT CRYST D, 57, 2001, pp. 605-608
Authors:
Maenaka, K
van der Merwe, PA
Stuart, DI
Jones, EY
Sondermann, P
Citation: K. Maenaka et al., The human low affinity Fc gamma receptors IIa, IIb, and III bind IgG with fast kinetics and distinct thermodynamic properties, J BIOL CHEM, 276(48), 2001, pp. 44898-44904
Authors:
Dorrell, L
Willcox, BE
Jones, EY
Gillespie, G
Njai, H
Sabally, S
Jaye, A
DeGleria, K
Rostron, T
Lepin, E
McMichael, A
Whittle, H
Rowland-Jones, S
Citation: L. Dorrell et al., Cytotoxic T lymphocytes recognize structurally diverse, clade-specific andcross-reactive peptides in human immunodeficiency virus type-1 gag throughHLA-B53, EUR J IMMUN, 31(6), 2001, pp. 1747-1756
Authors:
Tafuro, S
Meier, UC
Dunbar, PR
Jones, EY
Layton, GT
Hunter, MG
Bell, JI
McMichael, AJ
Citation: S. Tafuro et al., Reconstitution of antigen presentation in HLA class I-negative cancer cells with peptide-beta 2m fusion molecules, EUR J IMMUN, 31(2), 2001, pp. 440-449
Authors:
Maenaka, K
Maenaka, T
Tomiyama, H
Takiguchi, M
Stuart, DI
Jones, EY
Citation: K. Maenaka et al., Nonstandard peptide binding revealed by crystal structures of HLA-B5101 complexed with HIV immunodominant epitopes, J IMMUNOL, 165(6), 2000, pp. 3260-3267
Authors:
Gao, GF
Willcox, BE
Wyer, JR
Boulter, JM
O'Callaghan, CA
Maenaka, K
Stuart, DI
Jones, EY
Van Der Merwe, PA
Bell, JI
Jakobsen, BK
Citation: Gf. Gao et al., Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8 alpha alpha, J BIOL CHEM, 275(20), 2000, pp. 15232-15238
Authors:
Glithero, A
Tormo, J
Haurum, JS
Arsequell, G
Valencia, G
Edwards, J
Springer, S
Townsend, A
Pao, YL
Wormald, M
Dwek, RA
Jones, EY
Elliott, T
Citation: A. Glithero et al., Crystal structures of two H-2D(b)/glycopeptide complexes suggest a molecular basis for CTL cross-reactivity, IMMUNITY, 10(1), 1999, pp. 63-74
Authors:
Mongkolsapaya, J
Grimes, JM
Chen, N
Xu, XN
Stuart, DI
Jones, EY
Screaton, GR
Citation: J. Mongkolsapaya et al., Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation, NAT ST BIOL, 6(11), 1999, pp. 1048-1053
Citation: K. Maenaka et al., Crystal structure of the human p58 killer cell inhibitory receptor (KIR2DL3) specific for HLA-Cw3-related MHC class I, STRUCT F D, 7(4), 1999, pp. 391-398
Authors:
Butters, TD
Sparks, LM
Harlos, K
Ikemizu, S
Stuart, DI
Jones, EY
Davis, SJ
Citation: Td. Butters et al., Effects of N-butyldeoxynojirimycin and the Lec3.2.8.1 mutant phenotype on N-glycan processing in Chinese hamster ovary cells: Application to glycoprotein crystallization, PROTEIN SCI, 8(8), 1999, pp. 1696-1701
Authors:
Robinson, RC
Radziejewski, C
Spraggon, G
Greenwald, J
Kostura, MR
Burtnick, LD
Stuart, DI
Choe, S
Jones, EY
Citation: Rc. Robinson et al., The structures of the neurotrophin 4 homodimer and the brain-derived neurotrophic factor/neurotrophin 4 heterodimer reveal a common Trk-binding site, PROTEIN SCI, 8(12), 1999, pp. 2589-2597
Authors:
Willcox, BE
Gao, GF
Wyer, JR
O'Callaghan, CA
Boulter, JM
Jones, EY
Van der Merwe, PA
Bell, JI
Jakobsen, BK
Citation: Be. Willcox et al., Production of soluble alpha beta T-cell receptor heterodimers suitable forbiophysical analysis of ligand binding, PROTEIN SCI, 8(11), 1999, pp. 2418-2423
Authors:
Ikemizu, S
Sparks, LM
Van der Merwe, PA
Harlos, K
Stuart, DI
Jones, EY
Davis, SJ
Citation: S. Ikemizu et al., Crystal structure of the CD2-binding domain of CD58 (lymphocyte function-associated antigen 3) at 1.8-angstrom resolution, P NAS US, 96(8), 1999, pp. 4289-4294
Authors:
Maenaka, K
Juji, T
Nakayama, T
Wyer, JR
Gao, GF
Maenaka, T
Zaccai, NR
Kikuchi, A
Yabe, T
Tokunaga, K
Tadokoro, K
Stuart, DI
Jones, EY
van der Merwe, PA
Citation: K. Maenaka et al., Killer cell immunoglobulin receptors and T cell receptors bind peptide-major histocompatibility complex class I with distinct thermodynamic and kinetic properties, J BIOL CHEM, 274(40), 1999, pp. 28329-28334